Yahoo! Finance: ATHX News

UPDATE - Compugen shares nearly double on Pfizer deal (at Reuters)

Wed, 23 Dec 2009 18:13:50 Etc/GMT

[$$] Stocks in the Spotlight Tuesday (at Barrons.com)

Tue, 22 Dec 2009 22:00:40 Etc/GMT

Stocks in the Spotlight Tuesday Jabil Circuit, KB Home, UAL and Athersys all rose.

Biotech Stocks: Drug stocks gain; Athersys soars for second day (at MarketWatch)

Tue, 22 Dec 2009 20:58:00 Etc/GMT

Drug stocks advance as shares of Athersys Inc. soar for the second day following news it has entered into a collaboration with Pfizer Inc. for its stem-cell therapy MultiStem.

Healthy Drug Deals (TheStreet.com TV)

Tue, 22 Dec 2009 13:53:17 Etc/GMT

http://us.news2.yimg.com/us.yimg.com/p/fi/26/55/36.jpg/yfinance/tscm/cramermarketupdates/10650456http://www.thestreet.com/

Athersys Holdings and Atlas Pipeline Holdings Lead Small-Cap Percentage Gainers (SmallCapInvestor.com)

Tue, 22 Dec 2009 05:00:00 Etc/GMT

AtherSys Inc and US Airways Group Lead Small-Cap Volume (SmallCapInvestor.com)

Tue, 22 Dec 2009 05:00:00 Etc/GMT

Athersys to Produce Stem-Cell Treatment with Pfizer (at Fox Business)

Mon, 21 Dec 2009 22:35:39 Etc/GMT

Equities Update: Broad Market Gains (at Seeking Alpha)

Mon, 21 Dec 2009 21:22:10 Etc/GMT

Biotech Stocks: Drug stocks climb; Athersys soars on Pfizer deal (at MarketWatch)

Mon, 21 Dec 2009 20:27:00 Etc/GMT

Drug stocks climb, following the broader market north, as shares of Athersys soar on news it has signed a deal with Pfizer for its stem-cell therapy product MultiStem.

Sanofi-Aventis Acquires Chattem in $1.9 Billion Cash Deal (at Seeking Alpha)

Mon, 21 Dec 2009 18:39:52 Etc/GMT

[video] Healthy Drug Deals (at TheStreet.com)

Mon, 21 Dec 2009 18:20:00 Etc/GMT

Pharma's Holiday Shopping Spree (at CNBC)

Mon, 21 Dec 2009 18:13:38 Etc/GMT

UPDATE - Athersys inks deal with Pfizer on stem-cell therapy (at Reuters)

Mon, 21 Dec 2009 15:44:08 Etc/GMT

A Slew of New Deals Move Pharma Stocks (Indie Research)

Mon, 21 Dec 2009 15:17:00 Etc/GMT

Some big names got into the action on Monday.

Incyte Licenses Drug to Eli Lilly (at TheStreet.com)

Mon, 21 Dec 2009 13:18:37 Etc/GMT

Athersys signs development deal with Pfizer (AP)

Mon, 21 Dec 2009 12:56:53 Etc/GMT

Athersys Inc. said Monday it signed a development deal with Pfizer Inc. worth $6 million upfront and potentially up to $105 million for an experimental stem cell therapy.

Pfizer Licenses Athersys Stem Cell Drug: BioBuzz (at TheStreet.com)

Mon, 21 Dec 2009 11:46:55 Etc/GMT

Pfizer agrees deal to develop Athersys therapy (at MarketWatch)

Mon, 21 Dec 2009 11:10:16 Etc/GMT

ATHERSYS, INC / NEW Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online)

Mon, 21 Dec 2009 11:02:13 Etc/GMT

Athersys Enters Into Global Agreement With Pfizer to Develop and Market MultiStem(R) for the Treatment of Inflammatory Bowel Disease (GlobeNewswire)

Mon, 21 Dec 2009 11:00:00 Etc/GMT

CLEVELAND -- Athersys, Inc. announced today that it has entered into an agreement with Pfizer Inc. to develop and commercialize MultiStem for the treatment of Inflammatory Bowel Disease .